QuantumSi orporated
Open
$0.99
Prev. Close
$0.99
High
$0.99
Low
$0.98
Market Snapshot
$186.36M
-1.8
-0.71
$3.06M
145
Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. The company is headquartered in Branford, Connecticut and currently employs 145 full-time employees. The company went IPO on 2020-09-04. The firm has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. The company has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
emptyResult
Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. The company is headquartered in Branford, Connecticut and currently employs 145 full-time employees. The company went IPO on 2020-09-04. The firm has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. The company has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
Recently from Cashu
QuantumSi Partners with Aperture to Enhance Forensic Economic Services Collaboration
Aperture, LLC Partners with QSI Consulting to Enhance Forensic Economic Services Aperture, LLC, a portfolio company of Genstar Capital, solidifies its commitment to expanding its forensic and litigati…
Quantum-Si Incorporated Prepares for Financial Transparency and Innovation in Proteomics
Quantum-Si Sets the Stage for Financial Transparency and Innovation in Proteomics Quantum-Si Incorporated, widely recognized as The Protein Sequencing Company™, is poised to unveil its financial resul…
Quantum-Si Showcases Protein Sequencing Innovations at Festival of Genomics UK 2025
Quantum-Si Showcases Innovations in Protein Sequencing at Festival of Genomics UK Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, is set to participate in the Festival of Genom…
Quantum-Si Showcases Cutting-Edge Protein Sequencing Innovations at Festival of Genomics UK
Quantum-Si Showcases Innovations at Festival of Genomics UK Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, is set to make a significant impact at the upcoming Festival of Geno…